Hormone replacement therapy for all? Not for everybody.
作者信息
Jacobs H S
机构信息
Cobbold Laboratories, Middlesex Hospital, London.
出版信息
BMJ. 1996 Aug 10;313(7053):351-2. doi: 10.1136/bmj.313.7053.351.
Abstract
摘要
相似文献
1
Hormone replacement therapy for all? Not for everybody.所有人都适合激素替代疗法吗？并非如此。
BMJ. 1996 Aug 10;313(7053):351-2. doi: 10.1136/bmj.313.7053.351.
2
Hormone replacement therapy and the breast. Women still want to have hormone replacement therapy.激素替代疗法与乳腺。女性仍希望接受激素替代疗法。
BMJ. 2002 Apr 13;324(7342):915; author reply 915.
3
[Acceptability of hormonal substitution after menopause].[绝经后激素替代疗法的可接受性]
Rev Med Brux. 1998 Sep;19(4):A181-4.
4
Controversies in cancer care: hormone replacement therapy after breast cancer: how shall we do no harm?癌症护理中的争议：乳腺癌后的激素替代疗法：我们如何做到不伤害患者？
Cancer Pract. 1998 Sep-Oct;6(5):296-8. doi: 10.1046/j.1523-5394.1998.00026.x.
5
Women's decisions about hormone replacement therapy after education and bone densitometry.接受教育并进行骨密度测量后女性关于激素替代疗法的决定。
CMAJ. 1998 Nov 17;159(10):1253-7.
6
The choice of estrogen replacement therapy after a diagnosis of breast cancer.乳腺癌诊断后的雌激素替代疗法选择。
Ann Surg Oncol. 1999 Mar;6(2):135-6. doi: 10.1007/s10434-999-0135-z.
7
What do women want?女人想要什么？
Br J Obstet Gynaecol. 1996 May;103 Suppl 13:104-6; discussion 106-7.
8
Hormone replacement therapy: women's decision-making process.激素替代疗法：女性的决策过程。
Soc Work Health Care. 1999;28(3):95-111. doi: 10.1300/J010v28n03_06.
9
Perimenopausal women's views on hormone replacement therapy.围绝经期女性对激素替代疗法的看法。
BMJ. 1990 May 5;300(6733):1196. doi: 10.1136/bmj.300.6733.1196.
10
Medical decisions regarding hormone therapy for menopausal women are significantly influenced by the media.关于绝经后女性激素治疗的医学决策受到媒体的显著影响。
Pharmacoepidemiol Drug Saf. 2007 Jan;16(1):28-31. doi: 10.1002/pds.1342.
本文引用的文献
1
Utilisation of hormone replacement therapy by women doctors.女医生对激素替代疗法的使用情况。
BMJ. 1995 Nov 25;311(7017):1399-401. doi: 10.1136/bmj.311.7017.1399.
2
The use of estrogens and progestins and the risk of breast cancer in postmenopausal women.绝经后女性使用雌激素和孕激素与患乳腺癌风险
N Engl J Med. 1995 Jun 15;332(24):1589-93. doi: 10.1056/NEJM199506153322401.
3
Endometrial disease after treatment with oestrogens and progestogens in the climacteric.更年期使用雌激素和孕激素治疗后的子宫内膜疾病
Br Med J. 1980 Mar 22;280(6217):822-4. doi: 10.1136/bmj.280.6217.822.
4
Symptoms of oestrogen deficiency associated with supraphysiological plasma oestradiol concentrations in women with oestradiol implants.接受雌二醇植入的女性中，与超生理血浆雌二醇浓度相关的雌激素缺乏症状。
BMJ. 1989 Sep 2;299(6699):601-2. doi: 10.1136/bmj.299.6699.601-a.
5
Prevalence and determinants of estrogen replacement therapy in elderly women.老年女性雌激素替代疗法的患病率及决定因素。
Am J Obstet Gynecol. 1990 Nov;163(5 Pt 1):1438-44. doi: 10.1016/0002-9378(90)90602-4.
6
Postmenopausal estrogen and prevention bias.绝经后雌激素与预防偏倚。
Ann Intern Med. 1991 Sep 15;115(6):455-6. doi: 10.7326/0003-4819-115-6-455.
7
Hormone replacement therapy and cardiovascular disease.激素替代疗法与心血管疾病
Br Med Bull. 1992 Apr;48(2):276-308. doi: 10.1093/oxfordjournals.bmb.a072548.
8
Postmenopausal hormone replacement therapy.绝经后激素替代疗法
BMJ. 1992 Dec 5;305(6866):1403-8. doi: 10.1136/bmj.305.6866.1403.
Zotero 插件